NEW YORK (GenomeWeb) – HiberGene said today that it has received CE marking for its HG Swift instrument for molecular diagnosis of infectious diseases.

The instrument is designed exclusively for use with the Dublin, Ireland-based company's portfolio of molecular infectious disease assays, including its recently launched HG Meningococcus, a test for bacterial meningitis, and its forthcoming HG GBS, a rapid test for Group B Streptococcus.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.